Galderma Laboratories, L.P.

FDA Regulatory Profile

Galderma Laboratories, L.P. appears in FDA public data with 2 recalls, 0 510(k) clearances, 7 FDA inspections, and 1 compliance action on record. Its most recent recall (D-1031-2016, Class III) was initiated on May 19, 2016.

Summary

Total Recalls
2
510(k) Clearances
0
Inspections
7
Compliance Actions
1

Recent Recalls

NumberClassProductDate
D-1031-2016Class IIIDoxycycline, USP Capsules 40 mg, Packaged in 30 ct Bottles, Rx Only. Marketed by: Prasco LaboratoriMay 19, 2016
D-1660-2012Class IIICapex Shampoo (fluocinolone acetonide), Topical Shampoo, 0.01%, Rx only, For Topical Use Only, 4 fl August 15, 2012